Mountain Valley MD Expands Advisory Team and Awards New Stock Options
Mountain Valley MD Holdings Inc. (MVMD) has expanded its strategic leadership team by appointing five new advisors with expertise spanning medicine, regenerative agriculture, technology, media, governance, and business development. Alongside these appointments, the company has granted incentive stock options to selected advisors and consultants as part of its long-term growth and commercialization strategy.
The announcement reflects MVMD’s continued focus on strengthening its leadership network as it advances commercialization efforts across its portfolio of health and wellness technologies. Company President and Chief Executive Officer Dennis Hancock said the additions bring complementary knowledge and relationships that will help accelerate commercial partnerships, expand U.S. market opportunities, and position the company for its next phase of growth.
MVMD Strengthens Advisory Network
Mountain Valley MD has deliberately assembled a diverse advisory team capable of supporting multiple aspects of its business strategy. The newly appointed advisors represent backgrounds in clinical medicine, consumer health, regenerative agriculture, technology innovation, intellectual property, communications, governance, and international business.
According to Hancock, these appointments build upon advisors introduced earlier this year and further strengthen the company’s ability to commercialize its technologies while expanding strategic partnerships.
The appointments also demonstrate MVMD’s intention to bridge scientific innovation with practical commercial execution, ensuring the company has experienced guidance across healthcare, agriculture, technology, and capital markets.
Dr. Zach Bush Brings Medical and Regenerative Agriculture Expertise
Among the most notable additions is Dr. Zach Bush, a triple board-certified physician specializing in internal medicine, endocrinology and metabolism, as well as hospice and palliative care.
Throughout his career, Dr. Bush has become widely recognized for his research and advocacy surrounding the relationship between human health, soil biology, regenerative agriculture, and the microbiome. After completing his medical training at the University of Virginia Health System, he served as both a clinical instructor and later Associate Medical Director of Hospice of the Piedmont.
Beyond clinical medicine, Dr. Bush has established himself as an entrepreneur, educator, and researcher focused on improving long-term health through better food systems and environmental stewardship.
He founded Seraphic Group and co-founded Farmer’s Footprint, a nonprofit organization dedicated to promoting regenerative agriculture while highlighting the connection between healthy soils, nutritious food production, environmental sustainability, and human wellness.
His commercial experience also includes the development of microbiome-support consumer health products through the ION product line, giving him valuable insight into both healthcare innovation and consumer product commercialization.
Erai Beckmann Adds Global Commercialization Experience
Joining MVMD as an advisor is entrepreneur and investor Erai Beckmann, who brings more than two decades of experience building businesses across health sciences, emerging technologies, and international markets.
Beckmann has founded, managed, and advised both private and publicly traded companies, focusing on commercialization strategy, regulatory compliance, strategic partnerships, international expansion, and capital markets.
He played an important role during the early development of the cannabinoid pharmaceutical industry, co-founding one of the first CBD pharmaceutical companies authorized to import products into Latin America.
His work also contributed to discussions involving Brazil’s medical CBD regulatory framework, where he collaborated with regulators, policymakers, physicians, and industry stakeholders during significant policy changes introduced in 2015.
Today, Beckmann serves as Founding Partner of Peace Through Trade, a Layer 1 blockchain ecosystem integrating artificial intelligence, digital infrastructure, and regulatory-focused technologies. He also oversees a private family office investing in sustainability, emerging technologies, and growth-stage companies.
His broad international experience is expected to support MVMD’s commercialization initiatives while strengthening opportunities in global markets.
Actor and Entrepreneur Mehcad Brooks Joins Advisory Team
MVMD has also appointed Mehcad Brooks, whose career combines entertainment, entrepreneurship, technology, and media innovation.
Brooks is widely recognized for acting roles in popular television series including Desperate Housewives, True Blood, Supergirl, Law & Order, as well as appearances in the Mortal Kombat film franchise.
Outside entertainment, Brooks has built several companies focused on media production and emerging technologies. He founded Defiant Media, MB Interactive, and Meta Film Ventures, organizations exploring the use of artificial intelligence and innovative digital technologies within content creation and media development.
His advisory experience includes serving on the Advisory Board of the Center for World Philosophy & Religion and on the board of The Peace Studio.
Brooks has also advocated for innovation in precision wellness and human performance, making his expertise particularly relevant to companies developing next-generation health technologies.
MVMD believes his ability to communicate with broad audiences while understanding emerging technology trends will complement its commercialization efforts.
Dr. Sanjeev Goel Strengthens Clinical Perspective
Canadian physician Dr. Sanjeev Goel joins MVMD with more than 25 years of experience in family medicine and preventative healthcare.
A graduate of the University of Toronto and certified by the College of Family Physicians of Canada, Goel currently leads Peak Human, a personalized health practice focused on longevity, preventative medicine, and optimizing human performance.
Throughout his medical career, he has worked in traditional family medicine while also providing remote medical services in Himalayan communities and delivering mindfulness education for healthcare professionals.
His research and educational work has explored subjects including biological rhythms, autophagy, hormesis, mindfulness, personalized longevity strategies, and healthy aging.
His combination of clinical practice and health innovation provides MVMD with additional expertise as the company continues developing technologies designed to improve human health outcomes.
Eric Zember Expands Technology and Governance Capabilities
Technology executive and attorney Eric Zember rounds out the advisory appointments.
Currently serving as General Counsel for Affinity Solutions, Zember advises on governance, artificial intelligence, financing, partnerships, regulatory compliance, and corporate growth strategies.
During his legal career, he has negotiated technology, software licensing, intellectual property, data, and artificial intelligence agreements valued at more than $1 billion.
His previous senior legal and strategic leadership roles with SAP and Lowe’s Companies provided significant experience managing complex commercial transactions and technology partnerships.
Zember also has extensive governance experience, previously serving on the Board of Directors of The Explorers Club, becoming the youngest individual ever elected to its board.
His academic research into memory and cognition has been published in respected scientific journals and publications, further reflecting his multidisciplinary background.
For MVMD, Zember’s expertise in intellectual property commercialization, governance, and strategic partnerships is expected to support future technology licensing and business expansion initiatives.
Supporting Commercial Growth
The addition of these advisors aligns with MVMD’s broader objective of accelerating commercialization across multiple sectors, including consumer health, regenerative agriculture, biotechnology, and advanced delivery technologies.
Collectively, the advisory group offers experience in:
- Clinical medicine and healthcare innovation
- Regenerative agriculture and food systems
- Consumer wellness products
- Technology commercialization
- Artificial intelligence
- Intellectual property strategy
- Corporate governance
- Strategic communications
- U.S. business development
- International market expansion
- Capital markets
By bringing together experts from diverse industries, MVMD aims to strengthen both scientific development and commercial execution as it advances existing and future initiatives.
Incentive Stock Options Granted
In addition to expanding its advisory network, Mountain Valley MD announced the issuance of incentive stock options to selected consultants and advisors under the company’s Stock Option Plan.
A total of 3,250,000 stock options were granted with an exercise price of $0.075 per share.
The options remain exercisable for five years and follow a staged vesting schedule designed to encourage long-term engagement:
- 20% vest immediately upon grant.
- 30% vest six months after the grant date.
- 50% vest twelve months after the grant date.
Any shares issued through the exercise of these options will remain subject to applicable Canadian Securities Exchange policies and securities law resale restrictions.
Aligning Advisors with Shareholder Value
Dennis Hancock said the stock option grants recognize the important contributions advisors and consultants make toward advancing the company’s objectives.
By linking compensation to long-term equity performance, MVMD seeks to align advisor interests with those of shareholders while encouraging sustained involvement as commercialization efforts continue.
The combination of expanded strategic leadership and equity-based incentives demonstrates the company’s commitment to building a strong foundation for future growth. As MVMD advances its commercialization strategy, the newly appointed advisors are expected to provide valuable expertise across healthcare, technology, agriculture, governance, communications, and international business development, helping position the company for continued expansion in both Canadian and U.S. markets.
Source Link:https://www.businesswire.com/
